Piper Jaffray Downgrades ResMed (RMD) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Macquarie Upgrades ResMed (RMD) to Neutral
April 28, 2016 7:08 AM EDTMacquarie upgraded ResMed (NYSE: RMD) from Underperform to Neutral.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $56.65 yesterday.
... MoreResMed (RMD) Misses Q3 EPS by 1c
April 26, 2016 4:14 PM EDTResMed (NYSE: RMD) reported Q3 EPS of $0.68, $0.01 worse than the analyst estimate of $0.69. Revenue for the quarter came in at $453.9 million versus the consensus estimate of $455.88 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
... More